Drug pricing
Jun 15, 2017
Sanofi invests; ICER pitches; $6M in NIH; Pfizer, Roche cancer drug pricing
Sanofi investing around $2B into biologics production over next 3 years Following the recent approval of two new biologics, Dupixent and Kevzara, and a pipeline stuffed full of large-molecule drugs, Sanofi will invest as much as €2 billion on its biologics manufacturing network over the next several years. The discl...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
